ActiveNANCT03968055

The Use of Continuous Glucose Monitor Technology and Remote Monitoring to Change Clinical Outcomes Following New Diagnosis of Type 1 Diabetes in the Pediatric Population

Sponsor: Stanford University

Trial Details

Condition	Type 1 Diabetes
Intervention	Integration with Epic
Phase	NA
Status	Active
Participants	100
Est. Completion	30 Dec 2025
Last Updated	8 May 2026

Primary Outcome

Contacts with the care provider

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic * Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic * Individuals who agree to CGM data integration into the electronic medical record (EMR) for remote monitoring * Age: birth to \< 21 years of age Exclusion Criteria: * Diabetes diagnosis other than T1D * Diagnosis of diabetes \> 1 month prior to initial visit * Individuals with the intention of obtaining diabetes care at another clinic * Individuals who do not consent to CGM use, CGM data integration, or remote monitoring * Individuals \> 21 years of age

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Stanford Trial Tests Remote CGM Monitoring to Transform Early Type 1 Diabetes Care — Digital Health Integration Study

Stanford University trial examines whether remote CGM monitoring can improve outcomes in newly diagnosed pediatric type 1 diabetes patients. The study integrates continuous glucose data into Epic EMR systems to enable proactive clinical interventions during the critical first year post-diagnosis.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service